Vector-borne rickettsioses in North Africa.
The purpose of this article is to overview vector-borne rickettsioses in North Africa, focusing on epidemiologic aspects, clinical features, diagnosis procedures, and treatment. The protective measures, the exposure to risk, and the dynamics of endemic emerging and re-emerging diseases in the region are detailed to minimize the risk when traveling in this area. In addition, the article describes the scientific contribution on the rickettsial field of North-African researchers from the beginning of the 20th century until today.
World Health Organization Collaborative Centre for Rickettsial Diseases and Other Arthropod-borne Bacterial Diseases, Aix Marseille University, 27 Boulevard Jean Moulin, 13005 Marseille, France.
Tahar
T
Kernif
Cristina
C
Socolovschi
Idir
I
Bitam
Didier
D
Raoult
Philippe
P
Parola
D000352:Africa, Northern; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D005334:Fever / Q000209:etiology; D006801:Humans; D008403:Mass Screening / Q000379:methods; D012282:Rickettsia Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D017282:Tick-Borne Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D004318:Doxycycline